Amica Mutual Insurance Co. Cuts Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Amica Mutual Insurance Co. decreased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 11.2% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 26,409 shares of the healthcare conglomerate’s stock after selling 3,347 shares during the period. UnitedHealth Group accounts for about 1.5% of Amica Mutual Insurance Co.’s investment portfolio, making the stock its 10th biggest position. Amica Mutual Insurance Co.’s holdings in UnitedHealth Group were worth $13,904,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Bray Capital Advisors raised its position in shares of UnitedHealth Group by 0.5% in the 3rd quarter. Bray Capital Advisors now owns 9,616 shares of the healthcare conglomerate’s stock worth $4,848,000 after acquiring an additional 50 shares in the last quarter. Sterling Investment Counsel LLC lifted its position in shares of UnitedHealth Group by 2.9% during the third quarter. Sterling Investment Counsel LLC now owns 3,237 shares of the healthcare conglomerate’s stock valued at $1,632,000 after buying an additional 92 shares during the last quarter. Ballentine Partners LLC grew its position in shares of UnitedHealth Group by 6.6% in the 3rd quarter. Ballentine Partners LLC now owns 18,354 shares of the healthcare conglomerate’s stock worth $9,254,000 after buying an additional 1,139 shares during the last quarter. KRS Capital Management LLC lifted its position in UnitedHealth Group by 3.7% during the third quarter. KRS Capital Management LLC now owns 2,557 shares of the healthcare conglomerate’s stock valued at $1,289,000 after acquiring an additional 92 shares during the last quarter. Finally, TFG Advisers LLC grew its holdings in UnitedHealth Group by 2.9% in the third quarter. TFG Advisers LLC now owns 8,591 shares of the healthcare conglomerate’s stock worth $4,331,000 after purchasing an additional 241 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several research analysts recently weighed in on UNH shares. Deutsche Bank Aktiengesellschaft boosted their target price on UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research note on Friday, April 19th. Bank of America reaffirmed a “buy” rating and issued a $675.00 price objective on shares of UnitedHealth Group in a research report on Thursday, March 7th. Barclays upped their price target on shares of UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a research note on Wednesday, April 17th. Wells Fargo & Company dropped their price objective on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a report on Monday, April 8th. Finally, TD Cowen lowered their price target on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a research report on Wednesday, April 10th. Four investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $570.05.

Insider Buying and Selling

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Corporate insiders own 0.35% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH stock traded down $6.35 during mid-day trading on Monday, hitting $489.00. 2,192,486 shares of the stock were exchanged, compared to its average volume of 4,479,956. The company has a market cap of $449.92 billion, a PE ratio of 29.89, a price-to-earnings-growth ratio of 1.43 and a beta of 0.54. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $554.70. The firm has a fifty day moving average of $485.19 and a 200 day moving average of $513.81. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. During the same quarter in the prior year, the firm earned $6.26 earnings per share. The business’s revenue was up 8.6% compared to the same quarter last year. Research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a $1.88 dividend. This represents a $7.52 annualized dividend and a dividend yield of 1.54%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 45.97%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.